Quick Answer
Armata Pharmaceuticals, Inc. reported Stockholders Equity of -$218.60 million for fiscal year 2025.
Armata Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$218.60M | -355.2% |
| 2024 | -$48.02M | -49.8% |
| 2023 | -$32.06M | -188.9% |
| 2022 | $36.08M | +42.1% |
| 2021 | $25.40M | +34.7% |
| 2020 | $18.86M | +29.2% |
| 2019 | $14.59M | +89.7% |
| 2018 | $7.69M | -68.4% |
| 2017 | $24.34M | +150.4% |
| 2016 | $9.72M | -23.5% |
| 2015 | $12.71M | +269.9% |
| 2014 | $3.44M | +115.2% |
| 2013 | -$22.62M | -274.8% |
| 2012 | $12.94M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$95.59M | -87.5% | -37.5% |
| June 30, 2025 | -$69.50M | -50.8% | -29.2% |
| March 31, 2025 | -$53.78M | +4.8% | -12.0% |
| December 31, 2024 | -$48.02M | -49.8% | +5.8% |
| September 30, 2024 | -$50.97M | -311.5% | -10.6% |
| June 30, 2024 | -$46.10M | -340.8% | +18.4% |
| March 31, 2024 | -$56.51M | -351.7% | -76.2% |
| December 31, 2023 | -$32.06M | -188.9% | -158.9% |
- Armata Pharmaceuticals, Inc. showed a decrease of -355.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, Armata Pharmaceuticals, Inc.’s stockholders equity has declined by 1788.9% (from $12.94 million to -$218.60 million).
- The most recent figure is from Armata Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: